Healthcare Global Gets Sebi Nod for IPO

New Delhi: Healthcare Global Enterprises Ltd (HCG), a cancer care network operator, has received approval of the Securities and Exchange Board of India (Sebi) to float an initial public offer (IPO).

The company filed its draft red herring prospectus (DRHP) with the capital markets regulator on July 27 for the IPO, wherein the promoters and other existing shareholders will collectively sell 3.11 crore shares of the company.

This comprises a fresh issue of up to 1.16 crore shares and an offer for sale of up to 1.95 crore scrips by existing stakeholders.

Sebi has cleared the proposed initial share sale and gave its final observations on the IPO on November 20.

The shares are proposed to be listed on the BSE and the National Stock Exchange (NSE).

The proceeds of the issue would be used for purchase of medical equipment, investment in IT software, services and hardware, payment of debt and for general corporate purposes.

The Bengaluru-based firm operates one of the largest cancer care networks in the country under the brand name 'HCG'. Currently, HCG has 15 comprehensive cancer centres.

Since the beginning of 2015, as many as 40 companies have filed draft documents with Sebi to float IPOs. In the same period, the market watchdog gave approval to 31 firms to launch their initial share sale plans, some of which were pending from previous year.

This year, 18 companies have so far launched IPOs and have collectively raised nearly Rs 11,000 crore, making it the best in four years in terms of fund raising through initial share sale programmes.

In comparison, six IPOs had hit the market in the entire 2014 and together garnered just Rs 1,261 crore, while three firms had launched their public issues in 2013 to mobilise Rs 1,284 crore.